News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
147 Results
Type
Article (2)
Press Release (145)
Section
Business (61)
Deals (11)
Drug Development (9)
FDA (1)
News (78)
Policy (3)
Tag
Alliances (19)
Approvals (1)
Cancer (1)
Clinical research (2)
COVID-19 (2)
Diagnostics (1)
Earnings (29)
Events (26)
FDA (1)
Government (1)
Healthcare (16)
Infectious disease (2)
IPO (7)
Mergers & acquisitions (4)
People (13)
Phase I (2)
Phase II (2)
Phase III (1)
Preclinical (8)
Regulatory (2)
Date
Last 30 days (2)
Last 365 days (22)
2024 (17)
2023 (24)
2022 (27)
2021 (34)
2020 (34)
2019 (3)
2018 (4)
2017 (4)
Location
Asia (2)
Canada (14)
China (1)
Europe (6)
147 Results for "immunoprecise".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer
ImmunoPrecise Antibodies Ltd. is pleased to announce the appointment of Kristin Taylor as Chief Financial Officer, effective immediately.
June 27, 2024
·
3 min read
Press Releases
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
November 5, 2024
·
5 min read
Press Releases
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
October 2, 2024
·
7 min read
News
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
October 21, 2024
·
1 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
Press Releases
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
September 27, 2024
·
9 min read
Press Releases
ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
October 10, 2024
·
5 min read
Press Releases
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
October 28, 2024
·
6 min read
BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces the commercial release of LENSai API, hereafter referred to as the ‘software’, by its subsidiary, BioStrand.
June 10, 2024
·
7 min read
Business
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
September 16, 2024
·
9 min read
1 of 15
Next
